+44 (0)118 970 2100
sales@vertec.co.uk
Unit 44 Easter Park
Benyon Road, Silchester
Reading, RG7 2PQ

IOeRT is a treatment which allows radiation to be applied to the tissue around the tumour in the operating room itself after the removal of the tumor mass, while the patient is still anaesthetised. The irradiation time takes less than two minutes.

Many of the early x-ray based systems proved to be ineffective with long exposure times combined with a weak reference trial based on a very short follow-up. SIT technology, based on linear electron systems, IOeRT, has become a consolidated, well accepted technique whose efficacy has proven by a large number of clinical studies and confirmed by the Update of the ASTRO Guidelines for Accelerated Partial Breast Irradiation (APBI) which define IOeRT as the recommended treatment as a single dose to be applied in the clinical practice outside a clinical trial.

Furthermore, National Comprehensive Cancer Network (NCCN) guidelines are now available for the IOeRT treatment of solid tumours such as sarcomas (extremity, trunk, H&N, retroperitoneal), rectal and colon cancer (T4 and recurrent), pancreatic cancer (close/positive margins), cervical and endometrial cancer (recurrent) and uterine sarcoma (recurrent).

SIT technology raises IOeRT to new levels of effectiveness and convenience, with obvious benefits terms of practicality and cost savings. The LIAC and NOVAC combine state-of-the-art technology with new designs that increase convenience and user-friendliness. No other mobile electronic accelerator in the world is so manoeuvrable, enabling fast, agile movement around operating rooms without compromising operating procedures. This makes IOeRT even more affordable as a single system covers the needs of several rooms, and patients can be treated on an standard operating table.

For more information, please download these papers:

2016 Update ASTRO APBI Guidelines

2006 Sedlmayer The Salzburg Concept

2013 Sedlmayer Boost Pooled Analysis

 

NCCN Guidelines

Breast Cancer 2016

Pancreatic Adenocarcinoma 2016

Rectal Cancer - highlighted 2016

Cervical Cancer 2017

Colon Cancer 2017

Sarcoma 2017

Uterine Neoplasms 2017

 

or the LIAC HWL brochure

or have a look at this stunning video


News

New SIGRT solution from C-RAD | News

17 Sep. 2020

C-RAD’s cutting-edge Surface Imaging Guided Radiation Therapy (SIGRT) solutions ensure excep...

Clark's Diagnostic Imaging Procedures | News

15 Mar. 2020

Vertec DXA applications specialist Sue Barlow is pictured with Mid Yorkshire NHS Trust consultant ...

Singleton considers C-RAD | News

22 Feb. 2020

Surface Image Guided Radiation Therapy (SIGRT) is a new and exciting technique that helps to deliv...

Fluoroscan at St George's | News

30 Jan. 2020

The highly successful consultant led hand unit at St George’s University Hospitals NHS Found...

Vertec at CoR Annual Radiotherapy Conference | News

31 Jan. 2020

Pictured at the College of Radiographers Annual Radiotherapy Conference (ARC) in Brighton recently...

Vertec to market Hyland Healthcare in UK | News

1 Dec. 2019

Vertec is partnering with Hyland Healthcare, a leading global provider of connected healthcare sol...


Vertec offer:

Our Partners
Imaging
Radiotherapy
Protection